U.S. Lung Cancer Screening Software Market – Industry Trends and Forecast to 2030

1. U.S. Lung Cancer Screening Software Market – Industry Trends and Forecast to 2030 The National Cancer Institute estimates that over 228,150 new cases of lung cancer were reported in the United States in 2019. According to the Lung Cancer Alliance, the 5-year survival rate for lung cancer has decreased dramatically from stage 1 diagnosis (68%-92% survival) to stage 4 diagnosis (0%-10% survival). Thus these are the key factor driving the market is the increasing number of screening programmes around the world. Data Bridge Market Research analyses that the lung cancer screening software market which is USD 14,214.86 thousand in 2022, is expected to reach USD 59,510.28 thousand by 2030, at a CAGR of 19.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. https://www.databridgemarketresearch.com/reports/us-lung-cancer-screening-software-market

2. Report Description Market Definition Lung cancer screening can be used to determine the stage of the disease. The most advised method for detecting lung cancer is through CT screening. It is anticipated that increased usage of this technology would increase the demand for sophisticated software for lung cancer screening. Using this software, healthcare workers may efficiently gather, organize and transfer data to clinicians and patients while managing patient involvement in lung screening programmes. Additionally, this programme makes it possible to identify patients who are at risk and streamlines data flow with linked electronic health records. Drivers Increase in prevalence of lung cancer cases globally The main cause of death for both men and women is lung cancer. According to World Cancer Research Fund International, lung cancer is the second most frequent cancer worldwide. In both men and women, it is the second most frequent kind of cancer. Lung cancer saw an increase of almost 2.2 thousand new cases in 2020. A major element in the market's growth is the rising incidence of lung cancer, which makes it necessary to employ lung cancer screening software for early diagnosis. Increase in awareness regarding the benefits of early diagnosis and frequent screening The market growth is predicted to be boosted by increased awareness campaigns for lung cancer by public, non-profit, and private organizations. These programmes work to promote research, lessen stigma and prejudice, and prevent sickness. Lung cancer has become a topic of greater public awareness. People are aware of lung cancer and how treatable it is if detected early because to the numerous awareness campaigns run by various organizations. As a result, increasing public awareness is fuelling market expansion. https://www.databridgemarketresearch.com/reports/us-lung-cancer-screening-software-market

3. Market Overview • U.S. Lung Cancer Screening Software Market Scope • Mode of Delivery • Cloud Based Solutions • On-Premise Solutions • Web Based Solutions • Product • Lung Cancer Screening Radiology Solution •  Lung Cancer Screening Patient Management Software •  Nodule Management Software •  Data Collection and Reporting •  Patient Coordination and Workflow •  Lung Nodule Computer Aided Detection •  Pathology and Cancer Staging •  Statistical Audit Reporting •  Screening PACS •  Practice Management •  Audit Log Tracking • https://www.databridgemarketresearch.com/reports/us-lung-cancer-screening-software-market

4. Key Players • Some of the major players operating in the lung cancer screening software market are: • Medtronic (Ireland) • PenRad Technologies Inc. (U.S.) • Koninklijke Philips N.V. (Netherlands) • Volpara Health Limited (U.S.) • Lungview (U.S.) • Siemens Healthcare Private Limited (Germany) • Thynk Health (U.S.) • E.ON SE (Germany) • Nuance Communications, Inc. (U.S.) • MeVis Medical Solutions AG (Germany) • Optellum Ltd (U.K.) • MyCareWare (U.S.) • ProVation Medical, Inc. (U.S.) • https://www.databridgemarketresearch.com/reports/us-lung-cancer-screening-software-market

5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Contact Us:- Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email:- corporatesales@databridgemarketresearch.com